MRD / Regn No. : SG004583 Date : 16/06/2026
Patient Name : Harshad Bhayani Age & Gender : 82 Yrs. / Male
Contact No. : 9874415001 UHID :
Ht / Wt / BMI : 170 / 76 / 26.30 BP S / BP D : 172 / 80
Allergies : NKA Referred By :
   
Problem List : TYPE 2 DIABETES (16/Jun/2020) | HYPERTENSION (16/Jun/2026) |
Salient Investigations : CREATININE: 1.3 | EGFR EGLOMERULAR FILTRATION RATE: 56.31 mL/min/1.73m2 | FASTING PLASMA GLUCOSE (FPG): 259 mg/dL | HB HEMOGLOBIN: 11 g/dL | HBA1C GLYCOSYLATED HEMOGLOBIN: 12.2 % | MICROALBUMIN CREATININE RATIO: 67.4 mcg/mg | POST PRANDIAL GLUCOSE (2HPP): 436 mg/dL
S# Generic (Trade) Name Route Dosage Usage Duration
1 ANTIHYPERGLYCEMIC GLICLAZIDE 60 MG + METFORMIN 500 MG
SECGLY M XR
PO 1-0-1 BEFORE BREAKFAST AND DINNER
TILL NEXT VISIT
2 ANTIHYPERGLYCEMIC DAPAGLIFLOZIN 10 MG + LINAGLIPTIN 5 MG
ZEXRIDA L
PO 1-0-0 BEFORE BREAKFAST
TILL NEXT VISIT
3 TABLET ROSUVASTATIN 20 MG
STATEZE R 20
PO 0-0-1 BEFORE DINNER
TILL NEXT VISIT
4 TABLET TELMISARTAN 40 MG
APEL 40
PO 1-0-0 BEFORE BREAKFAST
TILL NEXT VISIT
       
Refill : 0 / Substitution:    
Education :
Next Visit : 16/Dec/2026
Tests Suggested For Next Visit : CHECK FASTING AND PP AFTER 4 WEEKS AND INFORM,HBA1C-HPLC METHOD,RETINA CHECK UP,UACR:SPOT SAMPLE
   
   
User-Profile-Image
Dr. Samit Ghosal
MD (GM), Diploma in Diabetes Cardiff University, MSc (Diabetes Care) Glamorgan University, Diploma in Endocrinology Glamorgan University (USW), SCOPE certification in obesity management
West Bengal / 54020

This is a Computer generated Prescription

Powered By: